ISSAD.org

ISSAD.org Research Translation: Bridging the gap between laboratory science and clinical care.

Identifying and preventing morbidity and mortality caused by Streptococcus agalactiae.

4th International Symposium on ‘Streptococcus agalactiae’ Disease

24th - 26th February, 2026, Nairobi, Kenya Policy & Prevention: Discussing effective public health strategies and regulatory frameworks. Clinical Practice: Highlighting best practices and innovations in patient care.

26/02/2026

Day 2’s sessions shifted the focus to the GBS vaccine pipeline and the complex policy frameworks required to ensure global access.

It was an honor to hear from world-class experts including Prof. Shabir Madhi, Per Fischer, and Kirsty Le Doare. Whether discussing the "Last Mile First" or the economic case for national immunisation programs, the message was clear: Science alone isn’t enough, we need sustainable implementation and regional leadership.

The energy among our 37-country delegation remained high as we moved into the final day of the symposium!🔬

25/02/2026

"Collaboration is the bridge between policy and impact."

We were honoured to host Ms Mary Muthoni, CBS, Principal Secretary in the State Department for Public Health, at our gala dinner, where she delivered a powerful message on the future of maternal and neonatal health in Kenya. The PS underscored the government's commitment to integrating GBS prevention into broader public health frameworks and praised the collective efforts of the researchers and scientists in the room.

A call to action for all of us to ensure that every newborn has a healthy start, regardless of geography.

Science is driven by people, and last night was a testament to the dedicated individuals leading the fight against GBS.W...
25/02/2026

Science is driven by people, and last night was a testament to the dedicated individuals leading the fight against GBS.

We were privileged to be joined by Chief Guest PS MARY Muthoni, whose presence underscored the commitment to maternal and neonatal health at the highest levels. A significant moment of the evening was the presentation of the Carol Baker Award, recognizing outstanding contributions to our field.

Thank you to our speakers from Kenya Medical Research Institute (KEMRI) and the broader clinical community for reminding us why we move . Beyond the plenaries, these moments of networking and shared vision are where true partnerships are forged.

MaternalHealth

The science of GBS vaccines is advancing rapidly, but how do we implement them? In Plenary 4, we look at the evidence an...
24/02/2026

The science of GBS vaccines is advancing rapidly, but how do we implement them? In Plenary 4, we look at the evidence and economics behind the rollout.

Key Highlights:
📍 Policy Frameworks: Kirsty Le Doare on the evidence required by global health bodies.
📍 Effectiveness: Shamez Ladhani on the projected impact in the UK.
📍 The Business Case: Simon Procter on why GBS vaccines make economic sense for nations.

The world is watching as we move closer to a viable GBS vaccine. Plenary 3 at brings together the architects of the ne...
24/02/2026

The world is watching as we move closer to a viable GBS vaccine. Plenary 3 at brings together the architects of the next generation of maternal immunisation.

We are privileged to hear the latest clinical and preclinical updates from:
🔬 Per Fischer on the progress toward the pivotal trial for the AlpN Vaccine.
🔬 Shabir Madhi presenting interim results from the Phase 1/2 study of IVT GBS-06 in healthy adult non-pregnant women.
🔬 Roberto Adamo on the development of a Polysaccharide-Based GBS Vaccine tailored for global health.
🔬 Timothy Cooke on the preclinical development of a high-coverage 10-serotype Bioconjugate GBS Vaccine.

From the lab bench to phase trials, this is where the future of neonatal protection is being written. 🌍

A huge thank you to all our delegates for making Nairobi so memorable!Between the high-level plenaries and technical ses...
24/02/2026

A huge thank you to all our delegates for making Nairobi so memorable!

Between the high-level plenaries and technical sessions, it's been wonderful to see so many of you connecting (and having a little fun with our ISSAD frame!)

Plenary 1 at is diving deep into the Disease Burden & Surveillance of Group B Strep. We’re moving beyond the basics to...
23/02/2026

Plenary 1 at is diving deep into the Disease Burden & Surveillance of Group B Strep. We’re moving beyond the basics to look at infant impact, adult disease, and the genetic "fingerprints" of GBS across the globe.

Featuring:
👤 Ziyaad Dangor
👤 Namrata Prasad
👤 Dorota Jamrozy

Chaired by Prof Joy Lawn.

From Evidence to Action.

How can we improve GBS diagnosis at the point of care? Bio’s Prof. Vipul Bansal will be at answering that on Tuesday ...
21/02/2026

How can we improve GBS diagnosis at the point of care? Bio’s Prof. Vipul Bansal will be at answering that on Tuesday at 4 PM EAT.

He will discuss StrepSure®, a lateral flow device that brings rapid diagnosis directly to the delivery room. For clinicians and researchers looking to bridge the gap in intrapartum care, this is a session you cannot miss.

Session: Plenary C: Advancements in Diagnostics
Speaker: Prof. Vipul Bansal
Time: Tuesday, 24th Feb, 4:00 PM EAT
Venue: Hyatt Regency Westlands Nairobi (Muthithu)

With attendees traveling from 34 countries across 4 continents, represents a truly international effort.We gather in N...
20/02/2026

With attendees traveling from 34 countries across 4 continents, represents a truly international effort.

We gather in Nairobi next week, accelerating a global health revolution for mothers and newborns.

📅23 - 25 February, 2026
📍Nairobi, Kenya

As a member of WHO SAGE, Prof. Fiona Russell doesn't just study vaccines, she helps decide how they are used to save liv...
16/02/2026

As a member of WHO SAGE, Prof. Fiona Russell doesn't just study vaccines, she helps decide how they are used to save lives globally.

Her passion is in protecting mothers and babies through immunisation and ensuring that countries in Africa, Asia, and beyond have the data they need to implement successful vaccine programs. From the clinic to the highest levels of global policy, her work is moving the needle on GBS prevention.

Find her at
📅23 - 25 February, 2026
📍Nairobi, Kenya

Dr. Karen Puopolo’s career is a masterclass in translating basic science into clinical practice.Starting as a laboratory...
13/02/2026

Dr. Karen Puopolo’s career is a masterclass in translating basic science into clinical practice.

Starting as a laboratory scientist investigating GBS virulence, she has evolved into a leading voice in neonatal care. Her research on the long-term effects of intrapartum antibiotic prophylaxis (IAP) and preterm GBS infection has been foundational to the field.

Most notably, Dr. Puopolo has been instrumental in leading the revised U.S. national guidance for managing infants at risk for GBS disease.

Don't miss her session at
📅23 - 25 February, 2026
📍Nairobi, Kenya

Address

London School Of Hygiene And Tropical Medicine, Keppel Street
London
WC1E7HT

Website

Alerts

Be the first to know and let us send you an email when ISSAD.org posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to ISSAD.org:

Shortcuts

Share

Category